HOCPY
Price
$132.78
Change
+$2.46 (+1.89%)
Updated
Jan 17 closing price
Capitalization
41.52B
15 days until earnings call
IRME
Price
$0.68
Change
+$0.12 (+21.43%)
Updated
Jan 10 closing price
Capitalization
73.48M
38 days until earnings call
Ad is loading...

HOCPY vs IRME

Header iconHOCPY vs IRME Comparison
Open Charts HOCPY vs IRMEBanner chart's image
Hoya
Price$132.78
Change+$2.46 (+1.89%)
Volume$15.89K
Capitalization41.52B
IR-Med
Price$0.68
Change+$0.12 (+21.43%)
Volume$929
Capitalization73.48M
HOCPY vs IRME Comparison Chart
Loading...
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOCPY vs. IRME commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOCPY is a Hold and IRME is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (HOCPY: $132.78 vs. IRME: $0.68)
Brand notoriety: HOCPY and IRME are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HOCPY: 76% vs. IRME: 72%
Market capitalization -- HOCPY: $41.52B vs. IRME: $73.48M
HOCPY [@Medical Specialties] is valued at $41.52B. IRME’s [@Medical Specialties] market capitalization is $73.48M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOCPY’s FA Score shows that 0 FA rating(s) are green whileIRME’s FA Score has 0 green FA rating(s).

  • HOCPY’s FA Score: 0 green, 5 red.
  • IRME’s FA Score: 0 green, 5 red.
According to our system of comparison, HOCPY is a better buy in the long-term than IRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOCPY’s TA Score shows that 4 TA indicator(s) are bullish while IRME’s TA Score has 2 bullish TA indicator(s).

  • HOCPY’s TA Score: 4 bullish, 3 bearish.
  • IRME’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, HOCPY is a better buy in the short-term than IRME.

Price Growth

HOCPY (@Medical Specialties) experienced а +3.61% price change this week, while IRME (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

HOCPY is expected to report earnings on May 07, 2025.

IRME is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOCPY($41.5B) has a higher market cap than IRME($73.5M). IRME YTD gains are higher at: 45.447 vs. HOCPY (7.081). HOCPY has higher annual earnings (EBITDA): 267B vs. IRME (-5.22M). HOCPY has more cash in the bank: 426B vs. IRME (2.1M). IRME has less debt than HOCPY: IRME (185K) vs HOCPY (24.6B). HOCPY has higher revenues than IRME: HOCPY (734B) vs IRME (0).
HOCPYIRMEHOCPY / IRME
Capitalization41.5B73.5M56,463%
EBITDA267B-5.22M-5,118,865%
Gain YTD7.08145.44716%
P/E Ratio34.84N/A-
Revenue734B0-
Total Cash426B2.1M20,256,776%
Total Debt24.6B185K13,297,297%
FUNDAMENTALS RATINGS
HOCPY vs IRME: Fundamental Ratings
HOCPY
IRME
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
5591
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4957
P/E GROWTH RATING
1..100
58100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOCPY's Valuation (61) in the null industry is somewhat better than the same rating for IRME (95). This means that HOCPY’s stock grew somewhat faster than IRME’s over the last 12 months.

HOCPY's Profit vs Risk Rating (55) in the null industry is somewhat better than the same rating for IRME (91). This means that HOCPY’s stock grew somewhat faster than IRME’s over the last 12 months.

HOCPY's SMR Rating (100) in the null industry is in the same range as IRME (100). This means that HOCPY’s stock grew similarly to IRME’s over the last 12 months.

HOCPY's Price Growth Rating (49) in the null industry is in the same range as IRME (57). This means that HOCPY’s stock grew similarly to IRME’s over the last 12 months.

HOCPY's P/E Growth Rating (58) in the null industry is somewhat better than the same rating for IRME (100). This means that HOCPY’s stock grew somewhat faster than IRME’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOCPYIRME
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
44%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
70%
Bullish Trend 12 days ago
63%
Momentum
ODDS (%)
Bullish Trend 12 days ago
67%
Bearish Trend 12 days ago
73%
MACD
ODDS (%)
Bullish Trend 12 days ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
68%
Bullish Trend 12 days ago
52%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
66%
Bearish Trend 12 days ago
62%
Advances
ODDS (%)
Bullish Trend 12 days ago
66%
N/A
Declines
ODDS (%)
Bearish Trend 18 days ago
62%
N/A
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
69%
N/A
Aroon
ODDS (%)
Bearish Trend 12 days ago
66%
N/A
View a ticker or compare two or three
Ad is loading...
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
SUI.X5.0066140.127275
+2.61%
Sui cryptocurrency
PAXG.X2692.995000-12.396240
-0.46%
PAX Gold cryptocurrency
SRM.X0.030520-0.000230
-0.75%
Serum cryptocurrency
POWR.X0.272089-0.016282
-5.65%
Powerledger cryptocurrency
LEVER.X0.001759-0.000145
-7.62%
LeverFi cryptocurrency

HOCPY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOCPY has been loosely correlated with TRUMY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HOCPY jumps, then TRUMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOCPY
1D Price
Change %
HOCPY100%
+1.89%
TRUMY - HOCPY
47%
Loosely correlated
-0.95%
SSMXY - HOCPY
42%
Loosely correlated
-1.53%
ISRG - HOCPY
38%
Loosely correlated
+1.47%
OLYMY - HOCPY
36%
Loosely correlated
+0.14%
SMTI - HOCPY
34%
Loosely correlated
-0.21%
More